nach oben

Modern Rheumatology

Erschienen in:

01.06.2008 | Review Article

Osteoclast cell fusion: mechanisms and molecules

verfasst von: Masaru Ishii, Yukihiko Saeki

Erschienen in: Modern Rheumatology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Osteoclasts are bone-resorbing multinuclear polykaryon that are essential for bone remodeling and are formed through cell fusion of mononuclear macrophage/monocyte-lineage hematopoietic precursors. In arthritic joints, a large number of activated osteoclasts can be detected, which are suggested to be causative of bone erosion in rheumatoid arthritis. It has been fully established that osteoclastogenesis is critically regulated by several key essential factors, such as M-CSF and RANKL. However, regarding their most characteristic property, i.e., cell fusion to form giant polykaryons, there are still miscellaneous questions to be clarified, although several molecules have been shown to be critically involved in this process. Here we review the latest knowledge about osteoclastogenic cell fusion and novel concepts underlying the characteristic phenomenon. Because cell fusion is a genuine property of mature osteoclasts, modulating this process will become a promising therapeutic tool for bone resorptive disorders in the future.

Nur mit Berechtigung zugänglich

Bromley M, Bertfield H, Evanson JM, Woolley DE. Bidirectional erosion of cartilage in rheumatoid knee joints. Ann Rheum Dis. 1985;44:676–81.PubMedCrossRef

Kuratani T, Nagata K, Kukita T, Hotokebuchi T, Nakashima A, Iijima T. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol. 1988;13:751–9.

Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504–8.PubMedCrossRef

Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4:638–49.PubMedCrossRef

Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.PubMedCrossRef

Vignery A. Macrophage fusion: are somatic and cancer cells possible partners? Trends Cell Biol. 2005;15:188–93.PubMedCrossRef

Chen EH, Olson EN. Unveiling the mechanisms of cell–cell fusion. Science. 2005;308:369–73.PubMedCrossRef

Nixon B, Aitken RJ, McLaughlin EA. New insights into the molecular mechanisms of sperm-egg interaction. Cell Mol Life Sci. 2007;64:1805–23.PubMedCrossRef

Kaji K, Kudo A. The mechanism of sperm–oocyte fusion in mammals. Reproduction. 2004;127:423–9.PubMedCrossRef

10.

Taylor MV. Muscle differentiation: signaling cell fusion. Curr Biol. 2003;13:R964–6.PubMedCrossRef

11.

Prisk V, Huard J. Muscle injuries and repair: the role of prostaglandins and inflammation. Histol Histopathol. 2003;18:1243–56.PubMed

12.

Chen EH, Grote E, Mohler W, Vignery A. Cell–cell fusion. FEBS Lett. 2007;581:2181–93.PubMedCrossRef

13.

Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004;200:941–6.PubMedCrossRef

14.

Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T. DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202:345–51.PubMedCrossRef

15.

Baylies MK, Bate M, Ruiz-Gomez M. Myogenesis: a view from Drosophila. Cell. 1998;93:921–7.PubMedCrossRef

16.

Beckett K, Baylies MK. 3D analysis of founder cell and fusion competent myoblast arrangements outlines a new model of myoblast fusion. Dev Biol. 2007;309:113–25.PubMedCrossRef

17.

Bondesen BA, Jones KA, Glasgow WC, Pavlath GK. Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion. FASEB J. 2007;21:3338–45.PubMedCrossRef

18.

Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med. 2005;202:337–40.PubMedCrossRef

19.

Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol. 2000;81:291–304.PubMedCrossRef

20.

Saginario C, Qian HY, Vignery A. Identification of an inducible surface molecule specific to fusing macrophages. Proc Natl Acad Sci USA. 1995;92:12210–4.PubMedCrossRef

21.

Saginario C, Sterling H, Beckers C, Kobayashi R, Solimena M, Ullu E, Vignery A. MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol. 1998;18:6213–23.PubMed

22.

Han X, Sterling H, Chen Y, Saginario C, Brown EJ, Frazier WA, Lindberg FP, Vignery A. CD47, a ligand for the macrophage fusion receptor, participates in macrohage multinucleation. J Biol Chem. 2000;275:37984–92.PubMedCrossRef

23.

Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol. 1999;17:657–700.PubMedCrossRef

24.

Sterling H, Saginario C, Vignery A. CD44 occupancy prevents macrophage multinucleation. J Cell Biol. 1998;143:837–47.PubMedCrossRef

25.

Ohgimoto S, Tabata N, Suga S, Nishio M, Ohta H, Tsurudome M, Komada H, Kawano M, Watanabe N, Ito Y. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J Immunol. 1995;155:3585–92.PubMed

26.

Cui W, Cuartas E, Ke J, Zhang Q, Einarsson HB, Segdwick JD, Li J, Vignery A. CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts. Proc Natl Acad Sci USA. 2007;104:14436–41.PubMedCrossRef

27.

Mbalaviele G, Chen H, Boyce BF, Mundy GR, Yoneda T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest. 1995;95:2757–65.PubMedCrossRef

28.

Lemaire I, Falzoni S, Leduc N, Zhang B, Pellegatti P, Adinolfi E, Chiozzi P, Di Virgilio F. Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. J Immunol. 2006;177:7257–65.PubMed

29.

Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006;12:1403–9.PubMedCrossRef

30.

Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci. 2001;58:1189–205.PubMedCrossRef

31.

Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol. 2003;19:397–422.PubMedCrossRef

32.

Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6:801–11.PubMedCrossRef

33.

Tarrant JM, Robb L, van Spriel AB, Wright MD. Tetraspanins: molecular organizers of the leukocyte surface. Trends Immunol. 2003;24:610–7.PubMedCrossRef

34.

Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signaling and malignant disease. Tissue Antigens. 2004;64:533–42.PubMedCrossRef

35.

Kaji K, Oda S, Shikano T, Ohnuki T, Uematsu Y, Sakagami J, Tada N, Miyazaki S, Kudo A. The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet. 2000;24:279–82.PubMedCrossRef

36.

Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C. Severely reduced female fertility in CD9-deficient mice. Science. 2000;287:319–21.PubMedCrossRef

37.

Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A, Okabe M, Mekada E. Requirement of CD9 on the egg plasma membrane for fertilization. Science. 2000;287:321–4.PubMedCrossRef

38.

Tachibana I, Hemler ME. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol. 1999;146:893–904.PubMedCrossRef

39.

Ishibashi T, Ding L, Ikenaka K, Inoue Y, Miyado K, Mekada E, Baba H. Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J Neurosci. 2004;24:96–102.PubMedCrossRef

40.

Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, Mima T, Katada Y, Miyatake K, Uchiyama Y, Saeki Y. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res. 2006;21:965–76.PubMedCrossRef

41.

Yi T, Kim HJ, Cho JY, Woo KM, Ryoo HM, Kim GS, Baek JH. Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity. Biochem Biophys Res Commun. 2006;347:178–84.PubMedCrossRef

42.

Iwai K, Ishii M, Ohshima S, Miyatake K, Saeki Y. Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis. Rheumatol Int. 2008;28:225–31.PubMedCrossRef

43.

Takeda Y, Tachibana I, Miyado K, Kobayashi M, Miyazaki T, Funakoshi T, Kimura H, Yamane H, Saito Y, Goto H, Yoneda T, Yoshida M, Kumagai T, Osaki T, Hayashi S, Kawase I, Mekada E. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol. 2003;161:945–56.PubMedCrossRef

44.

Iwai K, Ishii M, Ohshima S, Miyatake K, Saeki Y. Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis. Allergol Int. 2007;56:457–63.PubMedCrossRef

45.

Tanio Y, Yamazaki H, Kunisada T, Miyake K, Hayashi SI. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis. Exp Hematol. 1999;27:853–9.PubMedCrossRef

46.

Hayashi S, Miyake K, Kinkade PW. The CD9 molecule on stromal cells. Leuk Lymphoma. 2000;38:265–70.PubMed

47.

Yamane H, Tachibana I, Takeda Y, Saito Y, Tamura Y, He P, Suzuki M, Shima Y, Yoneda T, Hoshino S, Inoue K, Kijima T, Yoshida M, Kumagai T, Osaki T, Eishi Y, Kawase I. Propionibacterium acnes-induced hepatic granuloma formation is impaired in mice lacking tetraspanin CD9. J Pathol. 2005;206:486–92.PubMedCrossRef

48.

Gordón-Alonso M, Yañez-Mó M, Barreiro O, Alvarez S, Muñoz-Fernández MA, Valenzuela-Fernández A, Sánchez-Madrid F. Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol. 2006;177:5129–37.PubMed

49.

Yáñez-Mó M, Alfranca A, Cabañas C, Marazuela M, Tejedor R, Ursa MA, Ashman LK, de Landázuri MO, Sánchez-Madrid F. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with α₃β₁ integrin localized at endothelial lateral junctions. J Cell Biol. 1998;141:791–804.PubMedCrossRef

50.

Sterk LM, Geuijen CA, van den Berg JG, Claessen N, Weening JJ, Sonnenberg A. Association of the tetraspanin CD151 with the laminin-binding integrins α₃β₁, α₆β₁, α₆β₄ and α₇β₁ in cells in culture and in vivo. J Cell Sci. 2002;115:1161–73.PubMed

51.

Cherukuri A, Shoham T, Sohn HW, Levy S, Brooks S, Carter R, Pierce SK. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol. 2004;172:370–80.PubMed

52.

Cherukuri A, Carter RH, Brooks S, Bornmann W, Finn R, Dowd CS, Pierce SK. B cell signaling is regulated by induced palmitoylation of CD81. J Biol Chem. 2004;279:31973–82.PubMedCrossRef

53.

Claas C, Stipp CS, Hemler ME. Evaluation of TM4SF protein complexes and their relation to lipid rafts. J Biol Chem. 2001;276:7974–84.PubMedCrossRef

54.

Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem. 2000;275:17221–4.PubMedCrossRef

55.

Kropshofer H, Spindeldreher S, Röhn TA, Platania N, Grygar C, Daniel N, Wölpl A, Langen H, Horejsi V, Vogt AB. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat Immunol. 2002;3:61–8.PubMedCrossRef

56.

Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387:569–72.PubMedCrossRef

57.

Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem. 1999;68:863–911.PubMedCrossRef

58.

Chernomordik LV Kozlov MM. Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem. 2003;72:175–207.CrossRef

59.

Pike LJ, Han X, Chung K-N, Gross RW. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 2002;41:2075–88.PubMedCrossRef

60.

Hope HR, Pike LJ. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell. 1996;7:843–5.PubMed

61.

Muller M, Zschornig O, Ohki S, Arnold K. Fusion, leakage and surface hydrophobicity of vesicles containing phosphoinositides: influence of steric and electrostatic effects. J Membr Biol. 2003;192:33–43.PubMedCrossRef

62.

Salaun C, James DJ, Chamberlain LH. Lipid rafts and the regulation of exocytosis. Traffic. 2004;5:255–64.PubMedCrossRef

Titel: Osteoclast cell fusion: mechanisms and molecules
verfasst von: Masaru Ishii
Yukihiko Saeki
Publikationsdatum: 01.06.2008
Verlag: Springer Japan
Erschienen in: Modern Rheumatology / Ausgabe 3/2008
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI: https://doi.org/10.1007/s10165-008-0051-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Osteoclast cell fusion: mechanisms and molecules

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Hyaluronan inhibits IL-1β-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells

Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol

Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy

Efficacy and safety of tacrolimus treatment for rheumatoid arthritis patients undergoing hemodialysis

Varicella–zoster virus hepatitis in polymyositis

Cavitary lung lesion in a patient with systemic lupus erythematosus: an unusual manifestation of cytomegalovirus pneumonitis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Innere Medizin